Schulman IRB’s oncology review experience is robust, including specialized research such as gene transfer protocols and targeted therapies.
Schulman serves as the national IRB for the Cancer Breakthroughs 2020 program and offers dedicated, expert oncology review services through its Central Oncology Review (COR) division.
Schulman’s IRB membership includes clinician researchers with significant oncology experience, and the IRB Chair has extensive oncology experience in an institutional setting. Her experience and personal professional network of oncology experts uniquely qualify her to lead the IRB in reviewing oncology research.
In addition to the IRB Chair’s experience, IRB members’ oncology-related expertise includes:
- Oncology research nursing
- Genetic counseling
- Medical oncology specialists
- Cancer and blood disorders
For more information on the IRB’s experience and expertise, please review our website or contact Business Development.